Consumption of legumes improves certain bone markers in ovariectomized rats

Soybeans are known to protect against osteoporosis, but other legumes frequently consumed in Asia have not been studied to learn if they have a similar protective effect. This study investigated the hypothesis that consumption of soybean, mung bean, cowpea, and adzuki bean has beneficial effects on bone biomarkers in ovariectomized rats. Female Sprague-Dawley rats were either sham operated (sham; n = 7) or surgically ovariectomized and then fed a regular AIN-93M diet (OVX; n = 7) or AIN-93M containing soybean (n = 7), mung bean (n = 7), cowpea (n = 7), or adzuki beans (n = 7) for 10 weeks. No bean consumption significantly altered the body, subcutaneous fat, or uterus weight; however, consumption significantly increased the serum calcium/phosphorous ratio and decreased urinary calcium excretion compared with those of the OVX group. Serum concentration of 17β-estradiol was significantly lower in the OVX group compared with that of the sham group and was lowest in the group fed OVX diet containing soybean. Serum osteocalcin concentration was significantly higher in all OVX rats given a diet with beans compared with the same diet without, but urinary deoxypyridinoline excretion was lowest in the group fed OVX diet containing cowpea. There were no significant differences in bone mineral density or bone mineral content of the right femur, tibia, or lumbar spine or in the trabecular bone volume of the tibia among the diet groups. In conclusion, the consumption of soybean, mung bean, cowpea, and adzuki bean in OVX rats improved osteocalcin, but only those fed cowpea showed decreased bone resorption biomarker, suggesting that cowpea may have the most protective effect on bone in OVX rats.     

Effects of dietary taurine supplementation on plasma and liver lipids in OVX rats fed calcium-deficient diet

Taurine supplementation has been shown to have an effect on lowering blood lipids in ovariectomized (OVX) rats. It therefore seemed desirable to find out whether the beneficial effect of taurine on OVX rats fed calcium-deficient diet could also be reproduced. Forty female Sprague-Dawley rats were divided into two groups. One group was OVX and the other group received a sham operation (Sham). Each rat group was further divided into the control diet and the taurine supplemented (2.0 g/100 g diet) diet group. All rats were fed on calcium-deficient diet and deionized water ad libitum for 6 weeks. Plasma and liver lipids were determined by using commercial kits. LDL-cholesterol concentrations were estimated with the equation of Friedewald et al. (1972). There were no significant differences in body weight gain and food intake between the control and taurine group within Sham and OVX groups, but body weight gain, food intake, and food efficiency ratio was higher in the OVX group. Concentrations of plasma total cholesterol, triglyceride, LDL-cholesterol were significantly lower in the taurine fed group of OVX rats fed Ca deficient diet, while HDL-cholesterol concentration was increased in the taurine fed group. Therefore, in this study, we examined whether taurine also prevented hypercholesterolemia induced by ovarian hormone deficiency in ovariectomized rats when they were fed a calcium-deficient diet. These results indicate that taurine may have some beneficial effects on hypercholesterolemia and hypertriglyceridemia in OVX rats fed calcium-deficient diet.     

Effect of dietary legumes on bone-specific gene expression in ovariectomized rats

In previous studies, we found that the consumption of legumes decreased bone turnover in ovariectomized rats. The purpose of the present study is to determine whether the protective effects on bone mineral density (BMD) and the microarchitecture of a diet containing legumes are comparable. In addition, we aim to determine their protective actions in bones by studying bone specific gene expression. Forty-two Sprague-Dawley rats are being divided into six groups during the 12 week study: 1) rats that underwent sham operations (Sham), 2) ovariectomized rats fed an AIN-93M diet (OVX), 3) ovariectomized rats fed an AIN-93M diet with soybeans (OVX-S), 4) ovariectomized rats fed an AIN-93M diet with mung beans (OVX-M), 5) ovariectomized rats fed an AIN-93M diet with cowpeas (OVX-C), and 6) ovariectomized rats fed an AIN-93M diet with azuki beans (OVX-A). Consumption of legumes significantly increased BMD of the spine and femur and bone volume of the femur compared to the OVX. Serum calcium and phosphate ratio, osteocalcin, expression of osteoprotegerin (OPG), and the receptor activator of nuclear factor κB ligand (RANKL) ratio increased significantly, while urinary excretion of calcium and deoxypyridinoline and expression of TNF-α and IL-6 were significantly reduced in OVX rats fed legumes, compared to OVX rats that were not fed legumes. This study demonstrates that consumption of legumes has a beneficial effect on bone through modulation of OPG and RANKL expression in ovariectomized rats and that legume consumption can help compensate for an estrogen-deficiency by preventing bone loss induced by ovarian hormone deficiency.     

Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats

We assessed the dose-dependent effects of daily soybean isoflavone (IF) consumption in reversing bone loss in adult ovariectomized rats. On d 0, female Wistar rats (7 mo old; n = 55) were either sham-operated (SH; n = 14) or ovariectomized (n = 41). On d 80, intermediate rats (SH: n = 5; ovariectomized: n = 5) were killed to confirm the ovariectomy-induced bone loss. The remaining ovariectomized rats were randomly assigned to one of four groups of nine rats each and fed soybean IF (mixed with a soy protein-free semipurified diet) at 0 (OVX), 20 (IF20), 40 (IF40) or 80 (IF80) mg/(kg body. d) for 84 d. Simultaneously, SH rats were fed the semipurified diet without any additional compound and killed on d 164, as were the other rats. As expected, both bone mineral density in the total femur and in its diaphyseal and metaphyseal subregions and cancellous bone area/measured surface in the distal femur metaphysis were lower in OVX than in SH rats (P: < 0.05). OVX rats had higher plasma osteocalcin concentration and urinary deoxypyridinoline excretion than SH rats (P: < 0.05). On d 164, osteocalcin and deoxypyridinoline concentrations were lower in IF40 or IF80 rats than in OVX rats (P: < 0.05). Nevertheless, neither bone mineral density nor cancellous bone area was greater in IF-fed rats than in OVX rats. Therefore, in adult ovariectomized rats, daily soybean IF consumption decreased bone turnover but did not reverse established osteopenia.     

Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats

We examined the effect of resveratrol (3,4',5-trihydroxy stilbene), a phenolic compound found in the skins of most grapes, on blood pressure and bone loss in ovariectomized (OVX), stroke-prone spontaneously hypertensive rats (SHRSP). Nineteen-week-old female SHRSP were divided into a sham-ovariectomized (sham) group fed a control diet and two OVX groups fed either a control diet (OVX-Cont) or a diet supplemented with resveratrol (5 mg/kg per d; OVX-Resv). Ovariectomy induced significant increases in systolic blood pressure (SBP). Resveratrol lowered the SBP by 15%) by the third week of administration, and this effect was maintained throughout the study. Resveratrol treatment also significantly enhanced endothelium-dependent vascular relaxation in response to acetylcholine (ACh) in OVX rats. Finally, femur breaking energies measured for the resveratrol-treated (OVX-Resv) group were significantly higher than those of the resveratrol-untreated (OVX-Cont) group. While no significant differences in calcium, magnesium and phosphorus content were found between the femurs of OVX-Cont and OVX-Resv rats, the femur hydroxyproline content in the OVX-Resv group was significantly higher than of the OVX-Cont group. We conclude that, in OVX-SHRSP, resveratrol acts by a similar mechanism to mammalian estrogens, lowering blood pressure by increasing dilatory responses to ACh. The present study also demonstrated that resveratrol was able to prevent ovariectomy-induced decreases in femoral bone strength.     

Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats

We evaluated the effect of magnesium supplementation on apparent calcium absorption, bone metabolism and dynamic bone strength in ovariectomized (OVX) rats as a model of postmenopausal women. Two groups of OVX rats were fed a 0.05% Mg diet or a 0.15% Mg diet, and one group of sham-operated rats was fed the 0.05% Mg diet for 42 d. We collected feces and urine of all rats for 3-d periods starting from d 3, 10, 17, 24, 31 and 38 of the feeding experiment for calcium and magnesium balance studies. Urine was collected for 24 h from d 41 of the feeding experiment for measuring deoxypyridinoline. After the 42 d, the rats were killed, serum prepared and femora excised. The apparent calcium absorption in the OVX rats fed 0.15% Mg was significantly lower than both other groups. Additionally, the urinary excretion of deoxypyridinoline (a bone resorption marker) and the serum parathyroid hormone level of the OVX rats fed the 0.15% Mg diet were significantly lower than in the OVX rats fed 0.05% Mg. Serum osteocalcin (a bone formation marker) in the OVX rats fed the 0.15% Mg diet was significantly higher than in the OVX rats fed 0.05% Mg. The breaking force and breaking energy of the femur in the OVX rats fed the 0.15% Mg diet were significantly higher than in the OVX rats fed the 0.05% Mg diet. These results indicate that magnesium supplementation reduces apparent calcium absorption, but promotes bone formation and prevents bone resorption in OVX rats. Moreover, our results indicate magnesium supplementation increases the dynamic strength of bone.     

Short- and long-term effects of calcium and exercise on bone mineral density in ovariectomized rats

At the level of prevention of bone mineral loss produced by ovariectomy, the aim of the present study was to determine the effect produced by supplementation of Ca in the diet and a moderate exercise programme (treadmill), simultaneously or separately, in ovariectomized rats, an experimental model of postmenopausal bone loss. Female Wistar rats (n 110, 15 weeks old) were divided into five groups: (1) OVX, rats ovariectomized at 15 weeks of age, fed a standard diet; (2) SHAM, rats sham operated at 15 weeks of age, fed a standard diet; (3) OVX-EX, ovariectomized rats, fed a standard diet and performing the established exercise programme; (4) OVX-Ca, ovariectomized rats fed a diet supplemented with Ca; (5) OVX-EXCa, ovariectomized rats with the exercise programme and diet supplemented with Ca. The different treatments were initiated 1 week after ovariectomy and were continued for 13 weeks for subgroup 1 and 28 weeks for subgroup 2, to look at the interaction of age and time passed from ovariectomy on the treatments. Bone mineral density (BMD) was determined, at the end of the study, in the lumbar spine (L2, L3 and L4) and in the left femur using a densitometer. Bone turnover was also estimated at the end of the study, measuring the serum formation marker total alkaline phosphatase (AP) and the resorption marker serum tartrate-resistant acid phosphatase (TRAP). As expected, OVX rats showed a significant decrease (P<0.05) in BMD, more pronounced in subgroup 2, and a significant increase in AP and TRAP with regard to their respective SHAM group. The simultaneous treatment with Ca and exercise produced the best effects on lumbar and femoral BMD of ovariectomized rats, partially avoiding bone loss produced by ovariectomy, although it was not able to fully maintain BMD levels of intact animals. This combined treatment produced a significant increase in AP, both in subgroups 1 and 2, and a decrease in TRAP in subgroup 1, with regard to OVX group. The exercise treatment alone was able to produce an increase in BMD with regard to OVX group only in subgroup 1 of rats (younger animals and less time from ovariectomy), but not in subgroup 2. In agreement with this, there was an increase of AP in both subgroups, lower than that observed in animals submitted to exercise plus Ca supplement, and a decrease of TRAP in subgroup 1, without significant changes in this marker in the older rats. Ca treatment did not produce any significant effect on BMD in OVX rats in both subgroups of animals, showing a decrease of AP and TRAP levels in the younger animals with no significant variations in markers of bone remodelling in the older female rats compared with their respective OVX group.     

Effect of tetracalcium dimagnesium phytate on bone characteristics in ovariectomized rats

The aim was to evaluate the influence of dietary Ca-Mg-phytate consumption on the bone characteristics of ovariectomized rats, an animal model for postmenopausal osteoporosis. Twenty ovariectomized female Wistar rats were randomly assigned to two groups fed, respectively, with a non-phytate diet (AIN-76A) or the same diet enriched with 1% phytate (as the calcium magnesium salt, phytin). After 12 weeks of feeding the rats were sacrificed, and both femoral bones and L4 vertebra were removed from each rat. Bone mass, length, width, volume, and mineral density were measured, and the phosphorus, calcium, magnesium, and zinc contents of bones were determined. Deoxypyridinoline (a bone resorption marker) was measured in urine, and osteocalcin (a bone formation marker) was measured in serum. The calcium and phosphorus contents and bone mineral density were significantly higher in both femoral bones and L4 vertebra for phytate-treated rats in comparison to rats in the non-phytate group. Deoxypyridinoline was significantly increased in rats in the non-phytate treatment group. Ca-Mg-phytate consumption reduces bone mineral density loss due to estrogen deficiency. Thus, phytate exhibits effects similar to those of bisphosphonates on bone resorption and may be of use in the primary prevention of osteoporosis if larger studies in humans confirm these findings.     

葛根异黄酮对去卵巢大鼠骨骼质量的影响

目的:观察葛根异黄酮(TIP)对去卵巢大鼠骨骼质量的影响。方法:选用健康成年SD雌性大鼠40只,随机分为5组:假手术组、模型对照组、低、中、高剂量TIP组;假手术组切除卵巢旁脂肪组织,其余各组均切除双侧卵巢,建立去卵巢大鼠动物模型。按25、50、100 mg/kg 3个剂量的TIP分别给去卵巢大鼠灌胃3个月,实验结束后处死大鼠,用相关方法检测骨骼质量变化的指标。结果:中、高剂量TIP组动物的体重与相对应时相的模型组比较均有下降(P<0.05);中、高剂量TIP组大鼠股骨重量、骨钙含量与模型对照组比较增加(P<0.05);高剂量TIP组大鼠的血清钙含量增高,血清磷、骨钙素和碱性磷酸酶含量均低于模型对照组(P<0.05);中、高剂量TIP组大鼠的股中心BMD和远心BMD均随葛根异黄酮剂量的增加而增加,呈剂量—效应关系,与模型对照组比较差异均有显著性(P<0.05)。结论:一定剂量葛根异黄酮能提高骨钙含量、增加骨密度,对去卵巢大鼠骨骼质量有明显的改善作用。     

Milk whey protein enhances the bone breaking force in ovariectomized rats

We studied the effects of whey protein (WP) and fractionated WP (HWP; heat-stable WP, LWP; low M.W. WP, EWP; ethanol-precipitated WP) on calcium and bone metabolism in ovariectomized (OVX) rats. Six-week-old female Sprague-Dawley rats were ovariectomized and fed a low-calcium diet (0.03% Ca, 0.3% P) for 4 weeks. The rats were divided into five groups, Cont, WP, HWP, LWP and EWP group, and were fed a Cont diet (20% casein, 0.3% Ca) or a diet (19% casein, 0.3% Ca) containing 1% WP, HWP, LWP or EWP for 4 weeks. There were no significant differences in the calcium balance, serum calcium and calcitonin levels among the experimental groups. However, serum ALP activity of the HWP and EWP groups at 14 wks. were lower than that of the Cont group. The bone breaking strength and energy of femur of the HWP, LWP and EWP groups were higher than those of the Cont group. As for the amount of calcium, phosphorus, and magnesium in the femur, there were no significant differences among the experimental groups; however, the amounts of total amino acids in the femur of the HWP, LWP and EWP groups were higher than that of the Cont group. The amounts of proline and hydroxyproline (typical amino acids of collagen) in the femur of the HWP, LWP and EWP groups were also higher than those of the Cont group. These data indicate that milk WP contains active components that influence bone metabolism in OVX rats by increasing in bone protein such as collagen and enhance the bone breaking force (strength and energy). These results suggest that the active components are existed in heatstable, low M.W. and 30–70% ethanol-precipitated fraction, respectively.     

海尔福对去卵巢和铅中毒大鼠骨组织及血液影响的实验研究

目的:观察海尔福对去卵巢和铅中毒大鼠骨组织及血液影响,了解海尔福对去卵巢和铅中毒大鼠骨骨质疏松治疗作用,为雌激素缺乏和铅中毒所引致骨质疏松症的防治提供实验依据。方法:选取5月龄健康雌性大鼠100只,分成5组。对照组、去卵巢模型组(OVX)、铅中毒模型组(LPD)、海尔福+去卵巢模型组(H+OVX)和海尔福+铅中毒模型组(H+LPD)。16周后,麻醉大鼠取左心血,处死后取双侧股骨。股骨切片光镜观察骨组织形态结构,并对血液中的钙、磷、铅、碱性磷酸酶和雌二醇进行测定,数据进行统计学分析。结果:H+LPD组骨组织结构、血钙、血磷和血红蛋白及碱性磷酸酶和雌二醇正常;0VX组、LPD组和H+OVX组的血钙及血磷均明显降低(P﹤0.01),血碱性磷酸酶活力升高(P﹤0.01),骨组织形态呈现骨质疏松的病理改变;0VX组和H+OVX组的雌二醇降低(P﹤0.01);LPD组的血铅明显高于对照组(P﹤0.01)。结论:去卵巢和铅中毒均可引起大鼠骨质疏松,铅中毒影响血红蛋白合成,海尔福对铅中毒所致的大鼠骨质疏松有治疗作用,而对雌激素缺乏大鼠骨质疏松治疗无效。     

Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats

This study investigated whether soy isoflavone intake, with or without estrogen treatment, can reduce postmenopausal bone loss, and whether soy isoflavones can be an alternative for estrogen replacement therapy using a postmenopausal osteoporotic rat model in which ovariectomized female rats were fed a low calcium, high fat diet. Nine-week-old female Sprague-Dawley rats were ovariectomized and then fed low (0.1%) calcium diets with or without soy isoflavone supplementation (80 or 160 ppm) for 6 weeks. Some ovariectomized rats were fed the same diets but also injected with estrogen (10 microg/kg of body weight) subcutaneously. Serum calcium and phosphate levels were normal in all rats. Serum alkaline phosphatase activities were not affected by the treatments. Serum tartrate-resistant acid phosphatase activities and urinary hydroxyproline levels were not different between experimental groups. Bone mineral (calcium and phosphorus) contents were increased in the rats supplemented with 80 ppm soy isoflavone or the rats treated with only estrogen without soy isoflavone. Therefore, the effect of 80 ppm soy isoflavone supplementation was the same as estrogen injection, but there was no beneficial effect from combining soy isoflavones and estrogen injections. When 160 ppm soy isoflavone was used, the benefits were lessened or disappeared altogether. These results suggest that appropriate soy isoflavone supplementation prevents postmenopausal bone loss without estrogen injection and may have efficacy as an alternative to estrogen therapy.     

Catechin-rich oil palm leaf extract enhances bone calcium content of estrogen-deficient rats

ObjectivePostmenopausal estrogen deficiency often causes bone density loss and osteoporosis. This study evaluated the effects of an oral administration of oil palm leaf extract (OPL) on bone calcium content and structure, bone density, ash weights, and serum total alkaline phosphatase (T-ALP) of estrogen-deficient ovariectomized (OVX) rats.MethodsFemale Sprague-Dawley rats were divided into five experimental groups: 1) intact (normal control); 2) ovariectomized (OVX control), and OVX rats supplemented with 3) 2% (w/v) green tea (OVX + GT), 4) OPL 150 mg/kg of body weight, or 5) OPL 300 mg/kg of body weight in the drinking water.ResultsAfter 3 mo, the OVX control rats had significantly decreased femur and tibia masses (?5% and ?3%, respectively), ash (?15% and ?10%), calcium content (?0.5% and ?2.7%), and bone density and T-ALP concentrations (?40%) compared with intact rats. The catechin-rich OPL dose dependently increased the OVX bone density and structure, femur and tibia masses (by +8% and +12% respectively), ash (by +30% and +20% respectively), calcium (by +3% and +5%), and T-ALP concentrations (by +76%) compared with the OVX rats. The increases by OPL were higher than that in OVX + GT and control intact rats.ConclusionThe catechin-rich OPL increased the bone mass in estrogen-deficient rats by increasing osteoblast activities to higher levels than in normal rats and those supplemented with GT. This was shown by the modulation of serum T-ALP levels, bone calcium content, total mineral content, and bone histologic structure. The OPL is a potential inexpensive ingredient for protection against osteoporosis and influences bone metabolism by encouraging bone formation.     

大豆甙元对去卵巢大鼠骨代谢酶及骨重建的影响

目的探讨大豆甙元(daidzein,Daid)改善去卵巢大鼠骨代谢酶学指标及对骨重建的作用。方法60只3月龄雌性清洁级大鼠随机分为:假手术(Sham)、去卵巢(OVX)和4个不同剂量去势+大豆甙元组(OVX-D1～OVX-D4),共6组。Sham和OVX组大鼠每日灌服等量蒸馏水,OVX-D1、OVX-D2、OVX-D3和OVX-D4四组分别灌服25、50、75和100mg/kgbw的Daid。大鼠6个月后处死,收集血液、肝脏和股骨,测定钙、磷含量及骨代谢酶学指标。结果Daid可提高去卵巢大鼠血清Ca、P含量及超微量ATP酶的表达水平,降低血清碱性磷酸酶(ALP)、血清骨特异性抗酒石酸酸性磷酸酶(TRAP-5b),其作用与剂量有关。结论服用一定剂量的Daid,能够抑制骨代谢相关酶的表达,进而抑制去卵巢大鼠的骨形成与骨吸收,使骨吸收与骨形成作用达到新的偶联平衡,其作用机制主要是通过降低骨转换率来实现。     

Hesperidin,a citrus flavonoid,inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice

The purpose of this study was to examine whether hesperidin inhibits bone loss in ovariectomized mice (OVX), an animal model of postmenopausal osteoporosis. Forty 8-wk-old female ddY mice were assigned to five groups: a sham-operated group fed the control diet (AIN-93G), an OVX group fed the control diet, an OVX+HesA group fed the control diet containing 0.5 g/100 g hesperidin, and an OVX+HesB group fed the control diet containing 0.7 g/100 g alpha-glucosylhesperidin and an OVX+17beta-estradiol (E(2)) group fed the control diet and administered 0.03 micro g E(2)/d with a mini-osmotic pump. After 4 wk, the mice were killed and blood, femoral, uterine and liver were sampled immediately. Hesperidin administration did not affect the uterine weight. In OVX mice, the bone mineral density of the femur was lower than in the sham group (P < 0.05) and this bone loss was significantly prevented by dietary hesperidin or alpha-glucosylhesperidin. The Ca, P and Zn concentrations in the femur were significantly higher in the hesperidin-fed and E(2) groups than in the OVX group. Histomorphometric analyses showed that the trabecular bone volume and trabecular thickness in the femoral distal metaphysis were markedly decreased (P < 0.05) by OVX, and alpha-glucosylhesperidin significantly prevented this bone loss. Furthermore, hesperidin decreased the osteoclast number of the femoral metaphysis in OVX mice, as did E(2). Serum and hepatic lipids were lower in mice that consumed the hesperidin-containing diets (P < 0.05) than in the OVX group fed the control diet. These results suggest a possible role for citrus flavonoids in the prevention of lifestyle-related diseases because of their beneficial effects on bone and lipids.     

Nondigestible oligosaccharides increase calcium absorption and suppress bone resorption in ovariectomized rats

Nondigestible oligosaccharides (NDO) including inulin and fructooligosaccharides (FOS) have been reported to stimulate calcium absorption. Here we report the effect of a mixture of inulin and FOS (Raftilose Synergy 1, Orafti) on calcium and bone metabolism in ovariectomized (OVX) rats. OVX rats (6 mo old) were fed a semipurified diet for 3 mo in our animal care laboratory for stabilization after ovariectomy. They were then divided into two groups (n = 13/group) and fed either a control or a NDO-supplemented diet (55 g/kg) for 21 d. Catheters were placed in their jugular veins. After 2 d, a tracer ((45)Ca) was administered by gavage or i.v. and blood was sampled for up to 300 min. Urine and fecal samples were collected for 4 d after (45)Ca administration. Femurs were measured for bone mineral density (BMD), breaking strength, and total calcium. Calcium absorption, femoral calcium content, BMD, and bone balance (V(bal)) were significantly increased (P < 0.05) by NDO, whereas the bone resorption rate relative to the bone formation rate was significantly depressed by NDO. We conclude that feeding NDO at 5.5 g/100 g for 21 d has a positive effect on calcium absorption and retention in ovariectomized rats.     

Ovariectomy, dietary zinc, and bone metabolism in retired breeder rats

Bone mineral turnover was studied in sham and ovariectomized (ovax) retired breeder rats after 16 wk of dietary treatment. Rats were fed either a commercial rat diet (CRD) containing high calcium and cholecalciferol or egg-white diets (EWD) containing 2 g Ca/kg, 1,25-(OH)2cholecalciferol (5 micrograms/kg), and either 10 or 200 mg zinc/kg. In rats fed EWD, high Zn enhanced femoral Zn deposition and concentration but did not affect serum Ca levels, bone mineral content (BMC), or turnover. Serum Ca levels and BMC were greater in sham rats and there was a gain in femoral Ca and phosphorus compared with the loss of these minerals in ovax rats. In CRD-fed ovax rats, values for these variables were similar to those of CRD-fed shams and there was no bone mineral loss. These data suggest that ovarian function may be a prerequisite for the beneficial effects of diets containing 1,25-(OH)2cholecalciferol and low Ca on bone metabolism.     

白藜芦醇对去卵巢大鼠骨密度的影响

目的:探讨白藜芦醇(RES)对去卵巢大鼠骨密度(BMD)的影响。方法:48只SD大鼠随机分为6组,分别接受假手术(A)、去卵巢(B)、去卵巢+0.03mg/(kgbw·d)己烯雌酚(DES,C)、去卵巢+RES5、15和45mg/(kgbw·d)(D,E,F)90d后,用双能X线吸收法测定大鼠的骨密度,观察其改变。结果:B组大鼠各BMD测定指标均显著低于A组,D、E、F组全身和腰椎BMD均显著高于B组,E、F组整体股骨BMD显著高于B组。结论:白藜芦醇对去卵巢大鼠的骨丢失有抑制作用,以45mg/(kgbw·d)剂量对骨密度的保护效果最好。     

大豆异黄酮对去势大鼠骨代谢的影响

[目的]探讨大豆异黄酮改善激素缺乏大鼠骨营养状况及作用机制。[方法]选用卵巢切除大鼠所诱发的骨质疏松模型,给予大豆异黄酮治疗,同时设假手术组及模型对照组。3个月后测定大鼠骨密度、骨钙含量及骨代谢酶学指标。[结果]大豆异黄酮可提高去势大鼠的骨密度、骨钙含量;降低血清碱性磷酸酶(AKP)及抗酒石酸酸性磷酸酶(TRACP)的活性(P<0.05),其作用与剂量有关。[结论]大豆异黄酮能够增加去势大鼠的骨密度,有类似雌激素样作用,可有效防治卵巢切除大鼠的骨量丢失,其作用机制可能是通过降低骨转换率来实现。     

大豆异黄酮对去势大鼠骨量丢失的抑制作用研究

目的:研究大豆异黄酮(Soybeanisoflavone,SI)对去势后大鼠由于体内雌激素水平下降引起的骨量丢失的抑制作用。方法:腹腔手术切除大鼠双侧卵巢,分为对照组、SI组和雌激素对照组,并设假手术对照组,喂养16w后,测定雌二醇、骨生化指标、骨密度、骨钙、骨磷等指标,扫描电镜和组化分析观察骨小梁微观结构的变化。结果:SI显著降低血清中骨吸收指标TRAP活性,同时明显提高骨形成指标BGP含量;SI具有弱雌激素作用,可抑制去卵巢大鼠体内雌激素水平的下降,骨密度和骨钙、骨磷含量增加,松质骨的骨丢失得到抑制。结论:SI可降低骨吸收、促进骨形成,对去卵巢引起的骨量丢失有明显的抑制作用。